K40
Conditions
Interventions
Group 1: Under direct visualization using the laparoscope at the beginning of the operation the TAP block was conducted. While the abdominal cavity was insufflated, the surgeon palpated the lateral bo
Sponsors
HELIOS Klinikum Berlin-Buch
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients who received an UG-TAP block prior to primary laparoscopic IHR in TAPP technique were included.
Exclusion criteria
Exclusion criteria: Patients who underwent a conversion to open surgery were excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary endpoint: cumulative Need medication (CNM) of opioids Patients in the UG-TAP-Block received an average of 10.2 mg (SD 5.09) of morphine and oxycodone on the day of their operation. Individuals of IVG-TAP-Block group received an average of 8.71 mg (SD 5.34) of morphine and oxycodone on the day of their operation (p=0.134). Patients in the UG-TAP-Block received an average of 0.38 mg (SD 1.46) of piritramide on the day of their operation. Individuals in the IVG-TAP-Block group received an average of 0.71 mg (SD 2.73) of piritramide on the day of their operation (p=0.423; table 3). | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary endpoint: CNM of acetaminophen, metamizole and Nonsteroidal anti-inflammatory drugs Secondary endpoint: pain after surgery in the postanesthetic care unit on the day of operation Secondary endpoint: Postoperative complications Secondary endpoint: Length of Hospital stay Secondary endpoint: Operating time | — |
Countries
Germany
Contacts
Public ContactChristoph Paasch
HELIOS Klinikum Berlin-Buch
Outcome results
None listed